These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7702630)

  • 1. Compound heterozygous mutations affecting both hepatic and erythrocyte isozymes of pyruvate kinase.
    Uenaka R; Nakajima H; Noguchi T; Imamura K; Hamaguchi T; Tomita K; Yamada K; Kuwajima M; Kono N; Tanaka T
    Biochem Biophys Res Commun; 1995 Mar; 208(3):991-8. PubMed ID: 7702630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a 6 base pair insertion in West Highland White Terriers with erythrocyte pyruvate kinase deficiency.
    Skelly BJ; Wallace M; Rajpurohit YR; Wang P; Giger U
    Am J Vet Res; 1999 Sep; 60(9):1169-72. PubMed ID: 10490091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of three PCR-RFLPs in an intron of the porcine liver- and red cell-type pyruvate kinase (PKLR) gene.
    Knoll A; Stratil A; Moser G; Geldermann H
    Anim Genet; 2000 Jun; 31(3):234. PubMed ID: 10895322
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutations in the R-type pyruvate kinase gene and altered enzyme kinetic properties in patients with hemolytic anemia due to pyruvate kinase deficiency.
    Lakomek M; Huppke P; Neubauer B; Pekrun A; Winkler H; Schröter W
    Ann Hematol; 1994 Nov; 69(5):253-60. PubMed ID: 7948315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-->T transition at cDNA nt 110 (K37Q) in the PKLR (pyruvate kinase) gene is the molecular basis of a case of hereditary increase of red blood cell ATP.
    Beutler E; Westwood B; van Zwieten R; Roos D
    Hum Mutat; 1997; 9(3):282-5. PubMed ID: 9090535
    [No Abstract]   [Full Text] [Related]  

  • 6. Hereditary hemolytic anemia caused by diverse point mutations of pyruvate kinase gene found in Japan and Hong Kong.
    Kanno H; Wei DC; Chan LC; Mizoguchi H; Ando M; Nakahata T; Narisawa K; Fujii H; Miwa S
    Blood; 1994 Nov; 84(10):3505-9. PubMed ID: 7949104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited persistence of immature type pyruvate kinase and hexokinase isozymes in dog erythrocytes.
    Inaba M; Maede Y
    Comp Biochem Physiol B; 1989; 92(1):151-6. PubMed ID: 2706933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postnatal changes in canine erythrocyte pyruvate kinase isozymes.
    Mueggler PA; Carpenter S; Black JA
    Biochem Genet; 1983 Aug; 21(7-8):691-702. PubMed ID: 6626141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new pyruvate kinase mutation with hyperactivity in the mouse.
    Charles DJ; Pretsch W
    Biochem Genet; 1984 Dec; 22(11-12):1103-17. PubMed ID: 6529440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of impaired pyruvate kinase isozyme conversion in erythroid cells: a single amino acid substitution near the active site and decreased mRNA content of the R-type PK.
    Kanno H; Fujii H; Tsujino G; Miwa S
    Biochem Biophys Res Commun; 1993 Apr; 192(1):46-52. PubMed ID: 8476433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low substrate affinity of pyruvate kinase variant (PK Sapporo) caused by a single amino acid substitution (426 Arg-->Gln) associated with hereditary hemolytic anemia.
    Kanno H; Fujii H; Miwa S
    Blood; 1993 May; 81(9):2439-41. PubMed ID: 8481523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of pyruvate kinase-deficiency mutations that produce nonspherocytic hemolytic anemia.
    Baronciani L; Beutler E
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4324-7. PubMed ID: 8483951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitance of an active and an inactive mutant of red cell pyruvate kinase (PK).
    Zanella A; Rebulla P; Izzo C; Zanuso F; Sirchia G
    Scand J Haematol; 1979 Feb; 22(2):145-53. PubMed ID: 432551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a postsynthetic proteolytic transformation of human erythrocyte pyruvate kinase into L-type enzyme.
    Marie J; Garreau H; Kahn A
    FEBS Lett; 1977; 78(1):91-4. PubMed ID: 872942
    [No Abstract]   [Full Text] [Related]  

  • 15. The molecular basis of canine pyruvate kinase deficiency.
    Whitney KM; Goodman SA; Bailey EM; Lothrop CD
    Exp Hematol; 1994 Aug; 22(9):866-74. PubMed ID: 7520391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyruvate kinases from human erythrocytes and liver.
    Kahn A; Marie J
    Methods Enzymol; 1982; 90 Pt E():131-40. PubMed ID: 7154942
    [No Abstract]   [Full Text] [Related]  

  • 17. The immunological properties of pyruvate kinase. II. The relationship of the human erythrocyte isozyme to the human liver isozymes.
    Lincoln DR; Black JA; Rittenberg MB
    Biochim Biophys Acta; 1975 Dec; 410(2):279-84. PubMed ID: 54192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cDNA cloning of human R-type pyruvate kinase and identification of a single amino acid substitution (Thr384----Met) affecting enzymatic stability in a pyruvate kinase variant (PK Tokyo) associated with hereditary hemolytic anemia.
    Kanno H; Fujii H; Hirono A; Miwa S
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8218-21. PubMed ID: 1896471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoelectric focussing of normal human erythrocyte pyruvate kinase (PK) and PK variants with abnormal electrophoretic patterns.
    Oda E; Nakashima K; Shinohara K; Miwa S
    Clin Chim Acta; 1976 Apr; 68(2):93-8. PubMed ID: 1261063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte enzyme activities in myelodysplastic syndromes: elevated pyruvate kinase activity.
    Tani K; Fujii H; Takahashi K; Kodo H; Asano S; Takaku F; Miwa S
    Am J Hematol; 1989 Feb; 30(2):97-103. PubMed ID: 2913762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.